Citation

Houghton PJ, Germain GS, Harwood FC, Schuetz JD, Stewart CF, Buchdunger E, Traxler P.: Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Cancer Res, Volume 64 (7), 2004

Authors

Buchdunger E, Germain GS, Harwood FC, Houghton PJ, Schuetz JD, Stewart CF, Traxler P.

Journal

Cancer Res

Year

2004

DOI

10.1158/0008-5472.can-03-3344

PubMed

15059881

Machine-readable

REST APIRDF